Please read and agree to the terms and conditions of this site.
@techcrunch.com 2 months ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@xconomy.com 4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com 5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com 5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@techcrunch.com 7 years ago
Regenerative medicine today is like the internet in 1993